Dutasteride를 투여받은 전립선비대증 환자에서 전립선특이항원 및 전립선특이항원 밀도의 변화
The Change of Prostate-specific Antigen and Prostate- specific Antigen Density in Patients with Benign Prostatic Hyperplasia after Dutasteride Treatment
김병석, 박성열, 문홍상, 최홍용, 손영우, 김용태, 윤영은, 이상봉,
소속 상세정보
김병석 ( Kim Byeong-Seok )
한양대학교 의과대학 비뇨기과학교실
박성열 ( Park Sung-Yul )
한양대학교 의과대학 비뇨기과학교실
문홍상 ( Moon Hong-Sang )
한양대학교 의과대학 비뇨기과학교실
최홍용 ( Choi Hong-Yong )
한양대학교 의과대학 비뇨기과학교실
손영우 ( Son Young-Woo )
한양대학교 의과대학 비뇨기과학교실
김용태 ( Kim Yong-Tae )
한양대학교 의과대학 비뇨기과학교실
윤영은 ( Yoon Young-Eun )
한양대학교 의과대학 비뇨기과학교실
이상봉 ( Lee Sang-Bong )
한양대학교 의과대학 비뇨기과학교실
KMID : 0358320080490100893
Abstract
Purpose: Dihydrotestosterone(DHT) is key to the initiation and maintenance of abnormal prostatic growth in benign prostatic hyperplasia (BPH). Five α-reductase inhibitor reduces prostatic growth and serum prostate-specific antigen(PSA) by blocking the conversion of testosterone to DHT. Dutasteride is a dual(type 1 and 2) 5α-reductase inhibitor. We evaluated the effects of dutasteride on prostate volume, PSA, and PSA density in men with BPH.
Materials and Methods: A total of 83 men with a clinical diagnosis of BPH were treated with dutasteride and an alpha-blocker. We investigated the change in prostate volume, PSA, and PSA density 6 and 12 months after initiation of dutasteride therapy.
Results: After 6 months of dutasteride therapy, the total prostate volume was reduced from baseline by a mean of 15.46%, the PSA was reduced by a mean of 48.24%, and the PSA density was reduced by a mean of 37.97%(p＜0.001). After 12 months of dutasteride therapy, the total prostate volume was reduced from baseline by a mean of 23.3%, the PSA was reduced by a mean of 52.57%, and the PSA density was reduced by a mean of 36.2%(p＜0.001). There were no differences in the regression rate of PSA and PSA density, in contrast to prostate volume, between 6 and 12 months of dutasteride therapy by repeated measures ANOVA.
Conclusions: The findings in this study demonstrate that the actual PSA in men receiving dutasteride would be multiplied by 2 considering the PSA regression rate after 12 months.
키워드
5α-reductase inhibitor;Dutasteride;Prostate-specific antigen
원문 및 링크아웃 정보
등재저널 정보